UPDATE: Citigroup Initiates Coverage On Atara Biotherapeutics On New Lead Product Candidates
November 10, 2014 at 10:58 AM EST
In a report published Monday, Citigroup analyst Yaron Werber initiated coverage on Atara Biotherapeutics Inc (NASDAQ: ATRA) with a Buy ...